Literature DB >> 19948411

Pre-ischaemic conditioning of the pulmonary endothelium by immunotargeting of catalase via angiotensin-converting-enzyme antibodies.

Kai Nowak1, Christine Hanusch, Kathrin Nicksch, Roman P Metzger, Grietje Beck, Martha M Gebhard, Peter Hohenberger, Sergei M Danilov.   

Abstract

BACKGROUND: Alleviation of oxidative stress via targeted delivery of catalase to the pulmonary endothelium by conjugation of angiotensin-converting-enzyme (ACE) monoclonal antibodies attenuates lung injury in an in vivo model of warm lung ischaemia and reperfusion. This study evaluates treatment of lung allografts with conjugates of anti-ACE antibody with catalase (9B9-CAT) in the setting of hypothermic preservation and reports the effect on ischaemia/reperfusion injury in this model.
METHODS: Rats were injected 1h prior to lung harvesting with mouse immunoglobulin G (IgG) (negative controls), catalase only (CAT) or anti-ACE mAb 9B9 conjugated with catalase (9B9-CAT). Lungs were flushed with low-potassium dextran (LPD) solution, excised and stored at 4 degrees C for 4 and 8h. Grafts were isolated and directly reperfused at 37 degrees C for up to 180 min. Peak inspiratory pressure (PIP), pulmonary arterial pressure (PAP) and lung weight were measured during reperfusion. Anti-oxidative capacity and catalase activity were measured in frozen lung tissue and inflammatory parameters were detected during reperfusion in perfusate solution.
RESULTS: Cold ischaemia of 8h significantly increased lung weight gain, PIP and PAP in non-immune mouse IgG and CAT-treated lungs than in 9B9-CAT-treated lungs (p<0.005). Significantly higher catalase activity and anti-oxidative status were found in the lung tissue of animals conditioned with 9B9-CAT after 4 and 8h of cold storage than in animals treated with catalase (CAT) alone or in animals treated with non-immune mouse IgG (p<0.01).
CONCLUSION: These results validate immunotargeting by anti-ACE mAb conjugated with catalase as a prospective and specific strategy to augment anti-oxidative defence of the pulmonary endothelium during lung transplantation. Vascular immunotargeting of anti-oxidative enzymes could limit reactive oxygen species mediated ischaemia-reperfusion (I/R) injury of the lung and has the potential to become a promising modality for extension of the viability of banked transplantation tissue. Copyright (c) 2009 European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948411     DOI: 10.1016/j.ejcts.2009.10.029

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

2.  Endothelial targeting of antibody-decorated polymeric filomicelles.

Authors:  Vladimir V Shuvaev; Marc A Ilies; Eric Simone; Sergei Zaitsev; Younghoon Kim; Shenshen Cai; Abdullah Mahmud; Thomas Dziubla; Silvia Muro; Dennis E Discher; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2011-08-23       Impact factor: 15.881

Review 3.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

4.  Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.

Authors:  Makan Khoshnejad; Vladimir V Shuvaev; Katherine W Pulsipher; Chuanyun Dai; Elizabeth D Hood; Evguenia Arguiri; Melpo Christofidou-Solomidou; Ivan J Dmochowski; Colin F Greineder; Vladimir R Muzykantov
Journal:  Bioconjug Chem       Date:  2016-01-15       Impact factor: 4.774

5.  Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.

Authors:  Vladimir V Shuvaev; Samira Tliba; Jeremy Pick; Evguenia Arguiri; Melpo Christofidou-Solomidou; Steven M Albelda; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2010-10-31       Impact factor: 9.776

6.  Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.

Authors:  Vladimir V Shuvaev; Raisa Yu Kiseleva; Evguenia Arguiri; Carlos H Villa; Silvia Muro; Melpo Christofidou-Solomidou; Radu V Stan; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2017-12-29       Impact factor: 9.776

7.  Targeted modulation of reactive oxygen species in the vascular endothelium.

Authors:  Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2011-03-30       Impact factor: 9.776

8.  Omega-3 fatty acids moderate effects of physical activity on cognitive function.

Authors:  Regina L Leckie; Stephen B Manuck; Neha Bhattacharjee; Matthew F Muldoon; Janine M Flory; Kirk I Erickson
Journal:  Neuropsychologia       Date:  2014-05-09       Impact factor: 3.139

Review 9.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

Review 10.  Targeted interception of signaling reactive oxygen species in the vascular endothelium.

Authors:  Jingyan Han; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2012-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.